+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 6052251
Description Jump to:
The global sterile injectables CDMO market size was estimated at USD 4.25 billion in 2024 and is projected to grow at a CAGR of 9.61% from 2025 to 2030. The market growth is primarily driven by increasing pipeline and approvals of injectable drugs. Pharmaceutical companies are proactively focusing on developing injectable medications due to their numerous benefits, such as quicker onset of action, precise dosing, and enhanced patient adherence.

For instance, as per the U.S. Food and Drug Administration (FDA) report published in January 2024, the Center for Drug Evaluation and Research (CDER) approved 55 novel drugs in 2023. These medications included injectables, indicating a robust pipeline that is anticipated to drive an increase in the demand for contract manufacturing services for both commercial and research purposes, hence contributing to overall market growth.

The increasing demand for cellular and genetic therapies is driving the market’s growth. With the expansion of therapy pipelines, there is a rising requirement for specialized manufacturing capabilities provided by contract manufacturing organizations (CMOs). For instance, according to the American Society of Gene & Cell Therapy (ASGCT), 3,866 therapies are currently in development, spanning from preclinical stages through preregistration. Within this landscape, 2,082 therapies are categorized as gene therapies, which include genetically modified cell therapies like CAR T-cell therapies, constituting 53% of gene, cell, and RNA therapies. In addition, 862 therapies are nongenetically modified cell therapies, making up 22% of the overall gene, cell, and RNA therapies in development. Thus, a strong product pipeline and growing demand for advanced therapeutics are likely to enhance overall market demand.

Strategic initiatives undertaken by market participants, such as expanding sterile manufacturing facilities and engaging in collaborations and partnerships, are anticipated to bolster market growth throughout the projected period. For instance, in March 2024, Alcami Corporation company partnered with Tanvex CDMO, enhancing its capabilities in biologics manufacturing. Alcami would leverage its expertise in sterile filling, labeling, and packaging, while Tanvex would contribute its high-throughput bulk drug substance development services. The partnership aimed to expedite the delivery of sterile injectables, addressing the increasing demand for specialty therapeutics and complex biologics.

The high demand for sterile injectables propels growth in outsourced agreements amongst contract manufacturers and biopharmaceutical companies, thereby boosting the growth of the sterile injectable CDMO industry. The growing need for faster drug action, rapid absorption, and less drug concentration are a few major aspects contributing to the adoption of sterile injectables CDMO industry. Further, pharmaceutical firms actively involved in sterile injectable development and manufacturing are gaining traction to support monoclonal antibody therapies, large-molecule injectable drugs, and infectious disease-treating drugs. Several factors, including reduced time and cost-affordable research and development cycles of generic injectables and the growing advancements in rare disease treatments, are accelerating the market growth.

Advanced manufacturing techniques are crucial for ensuring the stability and efficacy of cancer therapies. Contract manufacturers specializing in sterile injectables, particularly those experienced in handling complex formulations and biologics, are well-equipped to address the specific requirements of oncology drugs. Sterile injectables are essential for delivering complex biologics and innovative treatment methods in cancer treatment, driving the growth of the sterile injectable contract manufacturing sector. The growth in outsourcing practices is expected to drive the expansion of the segment over the forecast period. Pharmaceutical companies, particularly those specializing in oncology, are increasingly turning to outsourcing manufacturing operations to streamline processes, cut costs, and capitalize on the specialized expertise offered by contract manufacturers. This shift has notably boosted the cancer sector's sterile injectable contract development and manufacturing market.

Global Sterile Injectables CDMO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global sterile injectables CDMO market report based on molecule type, product, service, therapeutic area, route of administration, end-use, and region.

Molecule Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Small Molecule
  • Large Molecule

Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Pre-filled Syringes
  • Vials and Ampoules
  • Specialty Injectables
  • Others

Service Outlook (Revenue, USD Million, 2018 - 2030)

  • Formulation Development
  • Analytical and Testing Services
  • Method Development and Validation
  • Stability Testing
  • Drug Substance
  • Stability Indicating Method Validation
  • Accelerated Stability Testing
  • Photostability Testing
  • Other Stability Testing Methods
  • Extractable & Leachable Testing
  • Others
  • Manufacturing
  • Clinical Trial Manufacturing
  • Commercial Manufacturing
  • Aseptic Fill-Finish Services
  • Packaging
  • Storage
  • Cold
  • Non-cold
  • Others

Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

  • Oncology
  • Cardiovascular Diseases
  • Central Nervous System Diseases
  • Infectious Disorders
  • Musculoskeletal Diseases
  • Hormonal Diseases
  • Others

Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

  • Subcutaneous (SC)
  • Intravenous (IV)
  • Intramuscular (IM)
  • Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Vietnam
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.2.1. Molecule Type
1.2.2. Product
1.2.3. Service
1.2.4. Therapeutic Area
1.2.5. Route of Administration
1.2.6. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.6.1. Region Wise Market: Base Estimates
1.6.2. Global Market: CAGR Calculation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Value-Chain-Based Sizing & Forecasting (Model 2)
1.7.3. QFD Model Sizing & Forecasting (Model 3)
1.7.4. Bottom-Up Approach (Model 4)
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Sterile Injectables CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Pipeline and Approvals of Injectables
3.2.1.2. Growing Demand for Biologics and Biosimilars Significantly Supported Market Growth
3.2.1.3. Rise in Investment Across Research & Development Activities for the Development of Novel Therapeutics
3.2.1.4. Increasing Demand for One-stop-shop CDMOs
3.2.1.5. Increasing Outsourcing Services by Pharmaceutical Companies
3.2.2. Market Restraint Analysis
3.2.2.1. Low Barriers to Market Penetration Have Resulted in Pricing Pressure
3.2.2.2. Challenges Related to Quality Control
3.2.2.3. Compliance issues while outsourcing
3.2.2.4. Contractual Obligation
3.3. Technological Advancements
3.4. Pricing Model Analysis
3.5. Clinical Trials Volume Analysis, 2023
3.5.1. Total Number of Clinical Trials, by Region (2023)
3.5.2. Total Number of Clinical Trials, by Phase (2023)
3.5.3. Total Number of Clinical Trials, by Study Design (2023)
3.5.4. Total Number of Clinical Trials, by Key Therapeutic Area (2023)
3.6. Sterile Injectables CDMO Market: Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL Analysis
3.7. COVID-19 Impact Analysis
Chapter 4. Sterile Injectables CDMO Market: Molecule Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Sterile Injectables CDMO Market Movement Analysis
4.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, by Molecule Type, 2018 to 2030 (USD Million)
4.4. Small Molecule
4.4.1. Small Molecule Market Estimates and Forecast, 2018 to 2030 (USD Million)
4.5. Large Molecule
4.5.1. Large Molecule Market Estimates and Forecast, 2018 to 2030 (USD Million)
Chapter 5. Sterile Injectables CDMO Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Sterile Injectables CDMO Market Movement Analysis
5.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Pre-filled Syringes
5.4.1. Pre-filled Syringes Market Estimates and Forecast, 2018 to 2030 (USD Million)
5.5. Vials and Ampoules
5.5.1. Vials and Ampoules Market Estimates and Forecast, 2018 to 2030 (USD Million)
5.6. Specialty Injectables
5.6.1. Specialty Injectables Market Estimates and Forecast, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)
Chapter 6. Sterile Injectables CDMO Market: Service Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Sterile Injectables CDMO Market Movement Analysis
6.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
6.4. Formulation Development
6.4.1. Formulation Development Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.5. Analytical and Testing Services
6.5.1. Analytical and Testing Services Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.5.2. Method Development and Validation
6.5.2.1. Method Development and Validation Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.5.3. Stability Testing
6.5.3.1. Stability Testing Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.5.3.2. Drug Substance
6.5.3.2.1. Drug Substance Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.5.3.3. Stability Indicating Method Validation
6.5.3.3.1. Stability Indicating Method Validation Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.5.3.4. Accelerated Stability Testing
6.5.3.4.1. Accelerated Stability Testing Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.5.3.5. Photostability Testing
6.5.3.5.1. Photostability Testing Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.5.3.6. Other Stability Testing Methods
6.5.3.6.1. Other Stability Testing Methods Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.5.4. Extractable & Leachable Testing
6.5.4.1. Extractable & Leachable Testing Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.5.5. Others
6.5.5.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.6. Manufacturing
6.6.1. Manufacturing Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.6.2. Clinical Trial Manufacturing
6.6.2.1. Clinical Trial Manufacturing Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.6.3. Commercial Manufacturing
6.6.3.1. Commercial Manufacturing Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.6.4. Aseptic Fill-Finish Services
6.6.4.1. Aseptic Fill-Finish Services Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.7. Packaging
6.7.1. Packaging Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.8. Storage
6.8.1. Storage Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.8.2. Cold
6.8.2.1. Cold Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.8.3. Non-cold
6.8.3.1. Non-cold Market Estimates and Forecast, 2018 to 2030 (USD Million)
6.9. Others
6.9.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)
Chapter 7. Sterile Injectables CDMO Market: Therapeutic Area Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Sterile Injectables CDMO Market Therapeutic Area Movement Analysis
7.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, Therapeutic Area, 2018 to 2030 (USD Million)
7.4. Oncology
7.4.1. Oncology Market Estimates and Forecast, 2018 to 2030 (USD Million)
7.5. Cardiovascular Diseases
7.5.1. Cardiovascular Diseases Market Estimates and Forecast, 2018 to 2030 (USD Million)
7.6. Central Nervous System Diseases
7.6.1. Central Nervous System Diseases Market Estimates and Forecast, 2018 to 2030 (USD Million)
7.7. Infectious Disorders
7.7.1. Infectious Disorders Market Estimates and Forecast, 2018 to 2030 (USD Million)
7.8. Musculoskeletal Diseases
7.8.1. Musculoskeletal Diseases Market Estimates and Forecast, 2018 to 2030 (USD Million)
7.9. Hormonal Diseases
7.9.1. Hormonal Diseases Market Estimates and Forecast, 2018 to 2030 (USD Million)
7.10. Others
7.10.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)
Chapter 8. Sterile Injectables CDMO Market: Route of Administration Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Sterile Injectables CDMO Market Route of Administration Movement Analysis
8.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, Route of Administration, 2018 to 2030 (USD Million)
8.4. Subcutaneous (SC)
8.4.1. Subcutaneous (SC) Market Estimates and Forecast, 2018 to 2030 (USD Million)
8.5. Intravenous (IV)
8.5.1. Intravenous (IV) Market Estimates and Forecast, 2018 to 2030 (USD Million)
8.6. Intramuscular (IM)
8.6.1. Intramuscular (IM) Market Estimates and Forecast, 2018 to 2030 (USD Million)
8.7. Others
8.7.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)
Chapter 9. Sterile Injectables CDMO Market: Modality by End Use Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Global Sterile Injectables CDMO Market End Use Movement Analysis
9.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, End Use, 2018 to 2030 (USD Million)
9.4. Pharmaceutical Companies
9.4.1. Pharmaceutical Companies Market Estimates and Forecast, 2018 to 2030 (USD Million)
9.5. Biopharmaceutical Companies
9.5.1. Biopharmaceutical Companies Market Estimates and Forecast, 2018 to 2030 (USD Million)
9.6. Others
9.6.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)
Chapter 10. Sterile Injectables CDMO Market: Regional Estimates & Trend Analysis
10.1. Regional Market Share Analysis, 2024 & 2030
10.2. Regional Market Dashboard
10.3. North America
10.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.3.2. U.S.
10.3.2.1. Key Country Dynamics
10.3.2.2. Competitive Scenario
10.3.2.3. Regulatory Framework
10.3.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.3.3. Canada
10.3.3.1. Key Country Dynamics
10.3.3.2. Competitive Scenario
10.3.3.3. Regulatory Framework
10.3.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.3.4. Mexico
10.3.4.1. Key Country Dynamics
10.3.4.2. Competitive Scenario
10.3.4.3. Regulatory Framework
10.3.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.4. Europe
10.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.4.2. UK
10.4.2.1. Key Country Dynamics
10.4.2.2. Competitive Scenario
10.4.2.3. Regulatory Framework
10.4.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.4.3. Germany
10.4.3.1. Key Country Dynamics
10.4.3.2. Competitive Scenario
10.4.3.3. Regulatory Framework
10.4.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.4.4. France
10.4.4.1. Key Country Dynamics
10.4.4.2. Competitive Scenario
10.4.4.3. Regulatory Framework
10.4.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.4.5. Italy
10.4.5.1. Key Country Dynamics
10.4.5.2. Competitive Scenario
10.4.5.3. Regulatory Framework
10.4.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.4.6. Spain
10.4.6.1. Key Country Dynamics
10.4.6.2. Competitive Scenario
10.4.6.3. Regulatory Framework
10.4.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.4.7. Denmark
10.4.7.1. Key Country Dynamics
10.4.7.2. Competitive Scenario
10.4.7.3. Regulatory Framework
10.4.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.4.8. Sweden
10.4.8.1. Key Country Dynamics
10.4.8.2. Competitive Scenario
10.4.8.3. Regulatory Framework
10.4.8.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.4.9. Norway
10.4.9.1. Key Country Dynamics
10.4.9.2. Competitive Scenario
10.4.9.3. Regulatory Framework
10.4.9.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.5. Asia Pacific
10.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.5.2. Japan
10.5.2.1. Key country dynamics
10.5.2.2. Competitive scenario
10.5.2.3. Regulatory framework
10.5.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
10.5.3. China
10.5.3.1. Key country dynamics
10.5.3.2. Competitive scenario
10.5.3.3. Regulatory framework
10.5.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
10.5.4. India
10.5.4.1. Key country dynamics
10.5.4.2. Competitive scenario
10.5.4.3. Regulatory framework
10.5.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
10.5.5. South Korea
10.5.5.1. Key country dynamics
10.5.5.2. Competitive scenario
10.5.5.3. Regulatory framework
10.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
10.5.6. Australia
10.5.6.1. Key country dynamics
10.5.6.2. Competitive scenario
10.5.6.3. Regulatory framework
10.5.6.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
10.5.7. Thailand
10.5.7.1. Key country dynamics
10.5.7.2. Competitive scenario
10.5.7.3. Regulatory framework
10.5.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
10.5.8. Vietnam
10.5.8.1. Key country dynamics
10.5.8.2. Competitive scenario
10.5.8.3. Regulatory framework
10.5.8.4. Vietnam market estimates and forecasts, 2018 to 2030 (USD Million)
10.5.9. Indonesia
10.5.9.1. Key country dynamics
10.5.9.2. Competitive scenario
10.5.9.3. Regulatory framework
10.5.9.4. Indonesia market estimates and forecasts, 2018 to 2030 (USD Million)
10.5.10. Malaysia
10.5.10.1. Key country dynamics
10.5.10.2. Competitive scenario
10.5.10.3. Regulatory framework
10.5.10.4. Malaysia market estimates and forecasts, 2018 to 2030 (USD Million)
10.5.11. Philippines
10.5.11.1. Key country dynamics
10.5.11.2. Competitive scenario
10.5.11.3. Regulatory framework
10.5.11.4. Philippines market estimates and forecasts, 2018 to 2030 (USD Million)
10.5.12. Singapore
10.5.12.1. Key country dynamics
10.5.12.2. Competitive scenario
10.5.12.3. Regulatory framework
10.5.12.4. Singapore market estimates and forecasts, 2018 to 2030 (USD Million)
10.6. Latin America
10.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.6.2. Brazil
10.6.2.1. Key Country Dynamics
10.6.2.2. Competitive Scenario
10.6.2.3. Regulatory Framework
10.6.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.6.3. Argentina
10.6.3.1. Key Country Dynamics
10.6.3.2. Competitive Scenario
10.6.3.3. Regulatory Framework
10.6.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.7. MEA
10.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.7.2. South Africa
10.7.2.1. Key Country Dynamics
10.7.2.2. Competitive Scenario
10.7.2.3. Regulatory Framework
10.7.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.7.3. Saudi Arabia
10.7.3.1. Key Country Dynamics
10.7.3.2. Competitive Scenario
10.7.3.3. Regulatory Framework
10.7.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.7.4. UAE
10.7.4.1. Key Country Dynamics
10.7.4.2. Competitive Scenario
10.7.4.3. Regulatory Framework
10.7.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
10.7.5. Kuwait
10.7.5.1. Key Country Dynamics
10.7.5.2. Competitive Scenario
10.7.5.3. Regulatory Framework
10.7.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
Chapter 11. Competitive Landscape
11.1. Market Participant Categorization
11.1.1. Market Leaders
11.1.2. Emerging Players
11.2. Service Heat Map Analysis (a comparative analysis of the players together)
11.3. Company Profiles
11.3.1. Boehringer Ingelheim International GmbH
11.3.1.1. Company Overview
11.3.1.2. Financial Performance
11.3.1.3. Service Benchmarking
11.3.1.4. Strategic Initiatives
11.3.2. Baxter Simtra BioPharma Solutions)
11.3.2.1. Company Overview
11.3.2.2. Financial Performance
11.3.2.3. Service Benchmarking
11.3.2.4. Strategic Initiatives
11.3.3. Vetter Pharma International GmbH
11.3.3.1. Company Overview
11.3.3.2. Financial Performance
11.3.3.3. Service Benchmarking
11.3.3.4. Strategic Initiatives
11.3.4. Recipharm AB
11.3.4.1. Company Overview
11.3.4.2. Financial Performance
11.3.4.3. Service Benchmarking
11.3.4.4. Strategic Initiatives
11.3.5. Aenova Group
11.3.5.1. Company Overview
11.3.5.2. Financial Performance
11.3.5.3. Service Benchmarking
11.3.5.4. Strategic Initiatives
11.3.6. Fresenius Kabi Contract Manufacturing (Fresenius Kabi AG)
11.3.6.1. Company Overview
11.3.6.2. Financial Performance
11.3.6.3. Service Benchmarking
11.3.6.4. Strategic Initiatives
11.3.7. Unither Pharmaceuticals
11.3.7.1. Company Overview
11.3.7.2. Financial Performance
11.3.7.3. Service Benchmarking
11.3.7.4. Strategic Initiatives
11.3.8. FAMAR Health Care Services
11.3.8.1. Company Overview
11.3.8.2. Financial Performance
11.3.8.3. Service Benchmarking
11.3.8.4. Strategic Initiatives
11.3.9. Ajinomoto Bio-Pharma
11.3.9.1. Company Overview
11.3.9.2. Financial Performance
11.3.9.3. Service Benchmarking
11.3.9.4. Strategic Initiatives
11.3.10. PCI Pharma Services
11.3.10.1. Company Overview
11.3.10.2. Financial Performance
11.3.10.3. Service Benchmarking
11.3.10.4. Strategic Initiatives
11.3.11. IDT Biologika GmbH
11.3.11.1. Company Overview
11.3.11.2. Financial Performance
11.3.11.3. Service Benchmarking
11.3.11.4. Strategic Initiatives
11.3.12. Alcami Corporation
11.3.12.1. Company Overview
11.3.12.2. Financial Performance
11.3.12.3. Service Benchmarking
11.3.12.4. Strategic Initiatives
11.3.13. Fareva Group
11.3.13.1. Company Overview
11.3.13.2. Financial Performance
11.3.13.3. Service Benchmarking
11.3.13.4. Strategic Initiatives
11.3.14. Eurofins Scientific
11.3.14.1. Company Overview
11.3.14.2. Financial Performance
11.3.14.3. Service Benchmarking
11.3.14.4. Strategic Initiatives
11.3.15. Siegfried AG
11.3.15.1. Company Overview
11.3.15.2. Financial Performance
11.3.15.3. Service Benchmarking
11.3.15.4. Strategic Initiatives
11.3.16. Torbay Pharmaceuticals
11.3.16.1. Company Overview
11.3.16.2. Financial Performance
11.3.16.3. Service Benchmarking
11.3.16.4. Strategic Initiatives
11.3.17. Pfizer CentreOne (Pfizer Inc)
11.3.17.1. Company Overview
11.3.17.2. Financial Performance
11.3.17.3. Service Benchmarking
11.3.17.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 List of Abbreviations
Table 4 Global Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 5 Global Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 6 Global Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 7 Global Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 8 Global Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 9 Global Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 10 Global Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 11 North America Sterile Injectables CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 12 North America Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 13 North America Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 14 North America Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 15 North America Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 16 North America Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 17 North America Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 18 North America Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 19 U.S. Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 20 U.S. Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 21 U.S. Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 22 U.S. Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 23 U.S. Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 24 U.S. Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 25 Canada Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 26 Canada Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 27 Canada Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 28 Canada Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 29 Canada Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 30 Canada Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 31 Mexico Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 32 Mexico Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 33 Mexico Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 34 Mexico Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 35 Mexico Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 36 Mexico Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 37 Europe Sterile Injectables CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 38 Europe Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 39 Europe Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 40 Europe Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 41 Europe Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 42 Europe Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 43 Europe Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 44 Europe Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 45 UK Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 46 UK Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 47 UK Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 48 UK Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 49 UK Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 50 UK Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 51 Germany Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 52 Germany Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 53 Germany Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 54 Germany Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 55 Germany Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 56 Germany Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 57 France Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 58 France Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 59 France Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 60 France Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 61 France Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 62 France Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 63 Italy Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 64 Italy Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 65 Italy Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 66 Italy Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 67 Italy Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 68 Italy Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 69 Spain Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 70 Spain Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 71 Spain Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 72 Spain Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 73 Spain Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 74 Spain Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 75 Denmark Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 76 Denmark Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 77 Denmark Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 78 Denmark Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 79 Denmark Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 80 Denmark Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 81 Sweden Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 82 Sweden Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 83 Sweden Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 84 Sweden Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 85 Sweden Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 86 Sweden Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 87 Norway Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 88 Norway Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 89 Norway Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 90 Norway Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 91 Norway Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 92 Norway Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 93 Asia Pacific Sterile Injectables CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 94 Asia Pacific Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 95 Asia Pacific Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 96 Asia Pacific Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 97 Asia Pacific Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 98 Asia Pacific Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 99 Asia Pacific Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 100 Asia Pacific Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 101 Japan Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 102 Japan Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 103 Japan Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 104 Japan Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 105 Japan Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 106 Japan Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 107 China Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 108 China Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 109 China Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 110 China Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 111 China Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 112 China Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 113 India Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 114 India Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 115 India Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 116 India Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 117 India Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 118 India Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 119 South Korea Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 120 South Korea Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 121 South Korea Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 122 South Korea Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 123 South Korea Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 124 South Korea Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 125 Australia Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 126 Australia Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 127 Australia Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 128 Australia Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 129 Australia Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 130 Australia Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 131 Thailand Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 132 Thailand Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 133 Thailand Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 134 Thailand Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 135 Thailand Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 136 Thailand Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 137 Vietnam Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 138 Vietnam Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 139 Vietnam Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 140 Vietnam Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 141 Vietnam Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 142 Vietnam Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 143 Indonesia Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 144 Indonesia Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 145 Indonesia Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 146 Indonesia Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 147 Indonesia Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 148 Indonesia Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 149 Malaysia Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 150 Malaysia Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 151 Malaysia Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 152 Malaysia Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 153 Malaysia Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 154 Malaysia Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 155 Philippines Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 156 Philippines Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 157 Philippines Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 158 Philippines Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 159 Philippines Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 160 Philippines Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 161 Singapore Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 162 Singapore Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 163 Singapore Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 164 Singapore Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 165 Singapore Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 166 Singapore Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 167 Latin America Sterile Injectables CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 168 Latin America Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 169 Latin America Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 170 Latin America Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 171 Latin America Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 172 Latin America Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 173 Latin America Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 174 Latin America Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 175 Brazil Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 176 Brazil Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 177 Brazil Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 178 Brazil Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 179 Brazil Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 180 Brazil Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 181 Argentina Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 182 Argentina Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 183 Argentina Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 184 Argentina Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 185 Argentina Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 186 Argentina Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 187 Middle East & Africa Sterile Injectables CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 188 Middle East & Africa Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 189 Middle East & Africa Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 190 Middle East & Africa Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 191 Middle East & Africa Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 192 Middle East & Africa Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 193 Middle East & Africa Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
Table 194 Middle East & Africa Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 195 South Africa Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 196 South Africa Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 197 South Africa Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 198 South Africa Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 199 Saudi Arabia Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 200 Saudi Arabia Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 201 Saudi Arabia Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 202 Saudi Arabia Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 203 UAE Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 204 UAE Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 205 UAE Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 206 UAE Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 207 Kuwait Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
Table 208 Kuwait Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 209 Kuwait Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 210 Kuwait Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Sterile injectables CDMO market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD model sizing & forecasting
Fig. 10 Bottom-up approach
Fig. 11 Market snapshot
Fig. 12 Competitive landscape snapshot
Fig. 13 Parent market outlook, 2023 (USD Billion)
Fig. 14 Ancillary market outlook, 2023 (USD Billion)
Fig. 15 Sterile injectables CDMO market dynamics
Fig. 16 US FDA biologics approval
Fig. 17 Average cost by phase
Fig. 18 Clinical trial cost per indication (USD millions)
Fig. 19 Average cost of clinical trials by major countries
Fig. 20 Porter’s five forces analysis
Fig. 21 Sterile injectables CDMO market: PESTEL analysis
Fig. 22 Sterile injectables CDMO market: Molecule type outlook and key takeaways
Fig. 23 Sterile injectables CDMO market: Molecule type movement analysis
Fig. 24 Small molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Large molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Sterile injectables CDMO market: Product outlook and key takeaways
Fig. 27 Sterile injectables CDMO market: Product movement analysis
Fig. 28 Prefilled syringes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Vials and ampoules market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Specialty injectables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Sterile injectables CDMO market: Service outlook and key takeaways
Fig. 33 Sterile injectables CDMO market: Service movement analysis
Fig. 34 Formulation development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Analytical and testing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Method development and validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Stability testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Drug substance market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Stability-indicating method validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Accelerated stability testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Photostability testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Other stability testing methods market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Extractable & leachable testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Clinical trial manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Commercial manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Aseptic fill-finish services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Packaging market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Storage market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Cold storage market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Non-cold storage market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Sterile injectables CDMO market: Therapeutic area outlook and key takeaways
Fig. 55 Sterile injectables CDMO market: Therapeutic area movement analysis
Fig. 56 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Central nervous system diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Infectious disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Musculoskeletal diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Hormonal diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Sterile injectables CDMO market: Route of administration outlook and key takeaways
Fig. 64 Sterile injectables CDMO market: Route of administration movement analysis
Fig. 65 Subcutaneous market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Intravenous (IV) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Intramuscular (IM) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Sterile injectables CDMO market: End-use outlook and key takeaways
Fig. 70 Sterile injectables CDMO market: End-use movement analysis
Fig. 71 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Biopharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Regional market: Key takeaways
Fig. 75 Regional marketplace: Key takeaways 1
Fig. 76 Regional marketplace: Key takeaways 2
Fig. 77 North America sterile injectables CDMO market estimates and forecast, 2018 - 2030 (, 2018 - 2030 (, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 US sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Canada sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Mexico sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Europe sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 UK sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Germany sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 France sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Italy sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Spain sterile injectables CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 Denmark sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Sweden sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 Norway sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 101 Asia Pacific sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 102 Japan sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 China sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 India sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 South Korea sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 Australia sterile injectables CDMO market estimates and forecast, 2018 - 2030, (USD Million)
Fig. 111 Thailand sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 112 Key country dynamics
Fig. 113 Vietnam sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 114 Key country dynamics
Fig. 115 Indonesia sterile injectables CDMO market estimates and forecast, 2018 - 2030, (USD Million)
Fig. 116 Key country dynamics
Fig. 117 Malaysia sterile injectables CDMO market estimates and forecast, 2018 - 2030, (USD Million)
Fig. 118 Key country dynamics
Fig. 119 Philippines sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 120 Key country dynamics
Fig. 121 Singapore sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 122 Latin America sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 123 Key country dynamics
Fig. 124 Brazil sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 125 Key country dynamics
Fig. 126 Argentina sterile injectable CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 127 Key country dynamics
Fig. 128 Colombia sterile injectable CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 129 Key country dynamics
Fig. 130 Chile sterile injectable CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 131 MEA sterile injectable CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 132 Key country dynamics
Fig. 133 South Africa sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 134 Key country dynamics
Fig. 135 Saudi Arabia sterile injectable CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 136 Key country dynamics
Fig. 137 UAE sterile injectable CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 138 Key country dynamics
Fig. 139 Kuwait sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 140 Key company categorization
Fig. 141 Service heat map analysis
Fig. 142 Competitive assessment analysis
Fig. 143 Strategic framework

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Baxter (Simtra BioPharma Solutions)
  • Vetter Pharma International GmbH
  • Recipharm AB
  • Aenova Group
  • Fresenius Kabi Contract Manufacturing (Fresenius Kabi AG)
  • Unither Pharmaceuticals
  • FAMAR Health Care Services
  • Ajinomoto Bio-Pharma
  • PCI Pharma Services
  • IDT Biologika GmbH
  • Alcami Corporation
  • Fareva Group
  • Eurofins Scientific
  • Siegfried AG
  • Torbay Pharmaceuticals
  • Pfizer CentreOne (Pfizer Inc)

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.29 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Asia-Pacific CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Asia-Pacific CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 140 Pages
  • Asia Pacific
From
Growth Opportunities in Sterile Injectable Outsourcing - Product Image

Growth Opportunities in Sterile Injectable Outsourcing

  • Report
  • 43 Pages
  • Global
From
Sterile Injectable Contract Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Sterile Injectable Contract Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 120 Pages
  • Global
From
Formulation Development Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Service (Preformulation, Formulation Development), By Formulation, By Therapeutic Area, By Region and Competition - Product Image

Formulation Development Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Service (Preformulation, Formulation Development), By Formulation, By Therapeutic Area, By Region and Competition

  • Report
  • 115 Pages
  • Global
From
Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region (Europe, APAC), And Segment Forecasts, 2024 - 2030 - Product Image

Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region (Europe, APAC), And Segment Forecasts, 2024 - 2030

  • Report
  • 145 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.